CRA economists advised counsel to Office Depot throughout a review by the US Federal Trade Commission (FTC) of its proposed $1.2 billion merger with OfficeMax. The FTC ultimately closed its Second Request investigation, noting that the merger is unlikely to lessen competition in the sale of consumable office supplies.

A global pharmaceutical company abandoned a product launch following unfavorable clinical trial results. When their stock price fell, they were sued for allegedly concealing product information. The court accepted CRA’s analysis and conclusion that the alleged information concealment was an unlikely reason for the price change.

Charles River Associates recently assisted a company that was losing $35 million annually. Our advice positioned them to earn $35 million annually—at which time their parent company chose to divest them, realizing a transaction price of $400 million.

Charles River Associates helped Sprint obtain a favorable outcome at trial when Vonage infringed on several of their patents related to voice-over-Internet protocol technology. Subsequent to that trial, we assisted Sprint in connection with negotiations that resulted in an $80 million settlement.

CRA provided accounting analysis and expert testimony in two cases decided by the US Supreme Court regarding mutual fund fees, ultimately contributing to our client’s successful defense.